Cobalt Defense Nixed In Suit Over Generic Boniva
A federal judge has dealt a blow to Cobalt Pharmaceuticals Inc. in a legal battle brought by Hoffmann-La Roche Inc. over a generic version of bone-loss drug Boniva, ruling that Cobalt's...To view the full article, register now.
Already a subscriber? Click here to view full article